SCYNEXIS Inc —— 季度现金流量表 (NASDAQ:SCYX) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 90.64 M67.92 M60.69 M51.07 M59.03 M 负债总额 35.57 M17.38 M16.23 M14.64 M9.65 M 权益总额 55.08 M50.53 M44.47 M36.43 M49.38 M 负债及股东权益总额 90.64 M67.92 M60.69 M51.07 M59.03 M 总债务 —2.06 M1.95 M1.82 M— 净债务 —-51.74 M-44.55 M-36.08 M—

新闻

SCYNEXIS, Inc. (SCYX) Discusses Transformative Asset Acquisition and Strategic Shift Toward ADPKD Therapeutics - Slideshow (NASDAQ:SCYX) 2026-04-01

Brookline Capital下调SCYNEXIS目标价，基于估值考量

Brookline Capital cuts SCYNEXIS stock price target on valuation

SCYNEXIsQ1每股收益及营收超出预期

Scynexis Inc earnings beat by $0.12, revenue topped estimates

SCYNEXIS在SCY-247静脉注射制剂试验中完成首批患者给药

SCYNEXIS doses first patients in SCY-247 IV formulation trial

JERSEY CITY - FDA grants fast track and QIDP designations to SCYNEXIS drug

Scynexis获得纳斯达克180天延期以满足上市要求

Scynexis receives 180-day extension from Nasdaq to meet listing requirements

SCYNEXIS获得700万美元年度拨款用于抗真菌研究

SCYNEXIS receives $7 million annual grant for antifungal research